Expertise in
2
conditions

Dongfeng F. Chen

232 Waihuan East Road, 
Guangzhou, CN 
Expertise in
2
conditions
232 Waihuan East Road, 
Guangzhou, CN 

Overview

Dongfeng Chen practices practicing medicine in Guangzhou, China.

Chen is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Fitz-Hugh-Curtis Syndrome, Ascites, Vascular Dementia, Liver Embolization, and Endoscopy.

They are actively involved in clinical research, co-authoring 243 peer reviewed articles and participating in 1 clinical trial.

Locations

232 Waihuan East Road, Guangzhou, 510006, China
Other Locations
10 Changjiang Branch Road, Changjiang, 400042, China
No. 12 Jichang Road, Guangzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Chinese Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Chinese Subjects With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Active_not_recruiting
Publish Date: May 22, 2026
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3

243 Total Publications

Correction: Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.
Correction: Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.
Journal: Cell death and differentiation
Published: March 11, 2026

Frequently Asked Questions about Dongfeng F. Chen

Is Dongfeng F. Chen a top-rated expert for Fitz-Hugh-Curtis Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dongfeng F. Chen is classified as an Advanced expert for Fitz-Hugh-Curtis Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Dongfeng F. Chen participate in research or clinical trials?

Yes. Dongfeng F. Chen has published 243 articles and abstracts on conditions like Fitz-Hugh-Curtis Syndrome. You can view a list of Dongfeng F. Chen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen's expertise for a condition
ConditionClose
      View All 47 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile